The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Injection site nodule 3
SANDOSTATIN LAR DEPOT Injection site thrombosis 3
SANDOSTATIN LAR DEPOT Injection site ulcer 3
SANDOSTATIN LAR DEPOT Injection site vesicles 3
SANDOSTATIN LAR DEPOT Insulin-like growth factor decreased 3
SANDOSTATIN LAR DEPOT International normalised ratio increased 3
SANDOSTATIN LAR DEPOT Intervertebral disc injury 3
SANDOSTATIN LAR DEPOT Intestinal polyp 3
SANDOSTATIN LAR DEPOT Iron deficiency anaemia 3
SANDOSTATIN LAR DEPOT Joint dislocation 3
SANDOSTATIN LAR DEPOT Lacrimation increased 3
SANDOSTATIN LAR DEPOT Large intestine polyp 3
SANDOSTATIN LAR DEPOT Laziness 3
SANDOSTATIN LAR DEPOT Leukaemia 3
SANDOSTATIN LAR DEPOT Lip and/or oral cavity cancer 3
SANDOSTATIN LAR DEPOT Lip swelling 3
SANDOSTATIN LAR DEPOT Liver abscess 3
SANDOSTATIN LAR DEPOT Liver injury 3
SANDOSTATIN LAR DEPOT Lymphoedema 3
SANDOSTATIN LAR DEPOT Mania 3

Total Records: 2,045     Number of Pages: 103